Qualitest Expands Recall To 250M Syringes
Generic-drug and medical device manufacturer Qualitest Pharmaceuticals Inc. has expanded a recall of its Accusure insulin syringes to include as many as 250 million syringes made in the last seven years,...To view the full article, register now.
Already a subscriber? Click here to view full article